opendata.bot
Company number
12570359

COVID BIOPHARMA LIMITED

Active
✓ Active company on the official register. Next accounts due 30 September 2026.

Company details

Registered name
COVID BIOPHARMA LIMITED
Company number
12570359
Registered office
1ST FLOOR 40-44, NEWMAN STREET, LONDON, W1T 1QD, ENGLAND
Company type
Private Limited Company
Incorporated on
23 April 2020
Status
Active
Age
6 years
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts — next due
30 Sept 2026
Accounts — last made up to
31 Dec 2024
Confirmation statement — next due
06 May 2027
Confirmation statement — last
22 Apr 2026

What the register says

Facts from the register, with the dates they are filed under. Not a score: what they mean is for you to judge, and every line can be checked against Companies House itself.

Companies House register snapshot, read 02/09/2026.

People with significant control

Beneficial owners holding over 25% of shares, voting rights or the right to appoint directors

Peter Kadas
owns 25–50% of shares · holds 25–50% of voting rights
Notified 23/04/2020

Corporate structure

Who controls this company, and who they control in turn

1 controller Drag to move · scroll to zoom · double-click to expand
Company Person Current control Ended

Connections

Peter Kadas
born 02/1962 · Israel owns 25–50% of shares · holds 25–50% of votes Notified 23/04/2020

Change history

Reconstructed from the dated records Companies House publishes

DateChangeWasNow
23/04/2020 Person with significant control added Peter Kadas

Financial highlights

Parsed from the filed statutory accounts (£ thousands, except employees)

Source: Companies House bulk data filed accounts (iXBRL)
Metric FY2024FY2023
Net assets 0 0

Documents for COVID BIOPHARMA LIMITED

Need this one company on file? Buy the document on its own — no plan required.

Company extract£1.99

The full registration record as held today — name, number, status, registered office, company type, previous names, officers, PSC and SIC codes, timestamped for your file.

PDF Order
Financial statements£3.99

Every figure the company’s own accounts state, across each filed period, with year-on-year movement. Most UK companies file small or micro-entity accounts — a balance sheet and a headcount, no turnover or profit.

PDF + CSV Order
Ownership report£3.99

Who controls the company: persons with significant control, the nature of that control, the ownership graph and every other company those controllers hold.

PDF Order

Data protection register

No entry found on the ICO register of fee payers under this name.

Not every organisation has to register — some are exempt. An absent entry is a question to ask, not a finding.

Get this company via API

Every field on this page is available as structured JSON behind one endpoint and one API key.

GET /v1/company/gb/12570359
X-Api-Key: $OPENDATA_KEY
Read the API docs

Frequently asked questions

What is the company number of COVID BIOPHARMA LIMITED?
According to the official registry, the company number of COVID BIOPHARMA LIMITED is 12570359.
Where is COVID BIOPHARMA LIMITED registered?
The registered office is 1ST FLOOR 40-44, NEWMAN STREET, LONDON, W1T 1QD, ENGLAND.
What is the SIC code of COVID BIOPHARMA LIMITED?
The nature of business is recorded under SIC code 72110 — Research and experimental development on biotechnology.
Who controls COVID BIOPHARMA LIMITED?
Peter Kadas is recorded as a person with significant control, and owns 25–50% of shares, holds 25–50% of voting rights.
When are the next accounts of COVID BIOPHARMA LIMITED due?
The next annual accounts are due by 30 September 2026, and the last accounts were made up to 31 December 2024.

About COVID BIOPHARMA LIMITED (12570359)

COVID BIOPHARMA LIMITED is a private limited company incorporated on 23 April 2020 and registered in the United Kingdom under company number 12570359. Its registered office is at 1ST FLOOR 40-44, NEWMAN STREET, LONDON, W1T 1QD, ENGLAND. The recorded nature of business is research and experimental development on biotechnology (SIC 72110). The company is currently active , with statutory accounts last made up to 31 December 2024. , and the person with significant control is Peter Kadas. This profile is provided by opendata.bot by Noetikos, aggregating official data from Companies House bulk data , last refreshed 2 September 2026.

Companies at the same registered office

Research and experimental development on biotechnology across UK registers

The same sector and the same company, seen through every register we hold

Explore by sector

Every UK company records what it does as a SIC code — browse the sectors around this one.